Affiliation:
1. Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
Abstract
Biological therapies have revolutionized medical treatment by targeting the key mediators or receptors involved in inflammatory responses, thereby effectively suppressing inflammation and achieving beneficial outcomes. They are more advanced than conventional therapies using corticosteroids and immunosuppressants, offering effective solutions for autoimmune diseases, cancer, transplant rejection, and various infectious diseases, including coronavirus disease 2019. Although they exert low immunosuppressive effects, biological therapies can reactivate specific biological targets associated with infections. This review summarizes the currently available biological therapies and discusses their immunosuppressive mechanisms and clinical applications, highlighting the variations in the types and frequencies of infection recurrence induced by different biological agents. Additionally, this review describes the risk factors associated with various biological agents, thus aiding clinicians in selecting the most appropriate biological therapy.
Funder
JSPS KAKENHI
Ministry of Health, Labor, and Welfare of Japan
Japan Agency for Medical Research and Development, AMED
Takeda Science Foundation
Reference125 articles.
1. Cai, Z., Wang, S., and Li, J. (2021). Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front. Med., 8.
2. Walsh, G., and Murphy, B. (1999). Biopharmaceuticals, an overview. Biopharmaceuticals, an Industrial Perspective, Springer.
3. The safety and side effects of monoclonal antibodies;Hansel;Nat. Rev. Drug Discov.,2010
4. Neutralizing monoclonal antibodies for treatment of COVID-19;Taylor;Nat. Rev. Immunol.,2021
5. The emerging safety profile of JAK inhibitors in rheumatic disease;Winthrop;Nat. Rev. Rheumatol.,2017